Global Omega-3 Market Benefited By Rising Consumption Of Omega-3 Fatty Acids

The increasing prevalence of health problems related to blood pressure and high triglyceride levels has led to the rising consumption of healthy food. The rising awareness among people about maintaining a healthy lifestyle has led to the increasing demand for DHA, EPA, and other omega-3 fatty acids. The increasing incidence of heart-related complications has further fuelled the demand for omega-3 fatty acids. The consumer preference is changing from junk food to healthy and organic food. This has boosted the demand for omega-3-based food products, states a new report added by MarketResearchReport.biz to its wide database of research reports. 

The report, titled ‘Global Omega-3 Market Outlook 2016-2021,’ briefs readers about the changing trends in the market during the period between 2016 and 2021. Changing trends and technological advancements are two of the key factors expected to propel the global market for omega-3 in the coming years, predict the analysts.

The research focuses on three key types of omega-3 acid, namely eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linoleic acid (ALA). All 3 are healthy fats and function differently in the body. Alpha-linoleic acid (ALA) offers limited health benefits, whereas DHA and EPA omega-3s are claimed to have life-sustaining benefits. The report further studies the competitive landscape and key companies operating in the global omega-3 market. 

The report also highlights various sources of omega-3 fatty acids, marine animals and plants being the primary ones. Marine sources of omega-3 include fish oil, krill oil, algal oil, and others. Plant-based sources of omega-3 comprise chia seed oil, flax seed oil, and others. Considering the many benefits of omega-3, its demand is expected to increase throughout the forecast period.

Regionally, the global omega-3 market is divided into Europe, Asia Pacific, the Middle East and Africa, and Rest of the World. North America leads the global market for omega-3, followed by Europe.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/776376

The global omega-3 market is highly competitive, as key companies are consistently taking efforts to introduce new omega-3 products that offer several health benefits. Omega-3 finds application in dietary supplements, pharmaceuticals, functional food and beverages, infant formula, and others.

DSM (Netherlands), Cargill (USA), Pronova (USA), Suntory (Japan), EPAX (Norway), Guangdong Runke (China), Cabio (China), Omega Protein (USA), Croda (UK), BioProcess Algae (USA), Lonza (Switzerland), Hubei Fuxing (China), and Kingdomway (China) are some of the key organizations operating in the global omega-3 market. At present, key companies are keen on merging with new entrants to maintain their dominance in the global market. Manufacturers are also focusing on new product launches and advancements in their production technologies. The rising investments in research and development activities can benefit the global market for omega-3, predict the analysts.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz

Global 3D Printing Materials Market Size, Research to grow at a CAGR of 25.39% during the period 2016-2020

The research study, titled “Global 3D Printing Materials Market 2016-2020,” offers a comprehensive analysis, focusing on the key dynamics estimated to influence the growth of the market in the coming few years. The key drivers, barriers, and current trends in the global 3D printing materials market have also been discussed in the research study to give a clear understanding of the market.

3D printing is an advanced technological process in which a digital design is used to create a three-dimensional (3D) object with the help of an additive procedure. In this method, the material is arranged in successive layers rather than cut and joined, in order to avoid any wastage. A 3D object is mostly designed using a 3D scanner or a computer-aided design software. In the last few years, 3D printing has gained immense popularity, owing to which the global market for 3D printing materials is projected to grow at a fast pace throughout the forecast period.

According to the research study, the global 3D printing materials market is estimated to register a 25.39% CAGR between 2016 and 2020. The rising support from governmental and nongovernmental organizations is anticipated to contribute significantly towards the development of the 3D printing materials market in the next few years. In addition, the growing demand for aircraft engines from original equipment manufacturers (OEMs) are estimated to augment the growth of the market in the near future.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/775772

On the other hand, the rapid technological development is leading to high production cost, which is estimated to hamper the growth of the global 3D printing materials market in the next few years. Moreover, the strict approval procedure is expected to result in legal disputes, curtailing the growth of the market in the near future. Nevertheless, the emergence of 3D bioprinting technology has created several growth opportunities for the key players in the global 3D printing materials market.

The 3D printing materials market across the globe is diversified and extremely competitive thanks to the presence of several vendors in the market. The leading players are emphasizing on expanding their product catalogue in order to cater to the rising demand for 3D printing materials across the globe. Moreover, these players are spending enormously on research and development activities to create a niche for themselves in the overall market in the next few years. The rapid development of diverse industries such as healthcare, aerospace, and automotive is encouraging the vendors to invest more in the next few years.

The prominent players engaged in the 3D printing materials market include Hoganas, EOS, Arcam, Sandvik, and Solvay. Some of the other key players discussed in the research study are Renishaw, ExOne, and Concept Laser. The key players in the market are focusing on precision and accuracy in order to sustain in the market and gain the competitive advantage in the coming few years.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz

Global Pharmaceutical Lab Equipment Market Rising Demands and Forecast Outlook 2016-2021

Advanced technologies are being consistently employed in laboratory equipment and devices to improve problem solving and treatment procedures. Reduction in operation cost, energy efficiency, minimal waste, and higher productivity are some of the benefits of modern-day pharmaceutical labs. 

Manufacturers of pharmaceutical lab equipment and devices are taking extra efforts to design and develop innovative and advanced lab equipment. Rapid development of the nanotechnology sector, system integration, micro processing, microfabrication, system integration, and advanced electronics have helped pharmaceutical labs design, develop, and maintain advanced equipment. These are the findings of the new report added by MarketResearchReport.biz to its database. 

The report, titled ‘Global Pharmaceutical Lab Equipment Market Outlook 2016-2021,’ focuses on the rising demand for new lab equipment in China and the changing trends in the global market. Lab equipment, biotechnology, pharma machinery, and analytical services in China are set for huge growth in the coming years. The improved quality of research and development activities and the use of advanced technology have helped manufacturers of lab equipment in new product launches. All these factors are expected to propel the China pharmaceutical lab equipment market in the coming years. 

The global market for pharmaceutical lab equipment is regionally divided into Asia (except China), China, North America, and EMEA. Backed by the growing business across all regions, pharmaceutical companies are introducing new lab equipment to fulfill the growing needs. Advanced technologies are predicted to bring about many changes in the design and features of lab equipment, predict the analysts.

As per the findings of the report, in the years to come, key pharma companies are expected to merge with the new entrants in the global market. The expected rise in the mergers, acquisitions, and partnership contracts between new entrants and key companies is predicted to propel the global market. By signing merging contracts, pharma companies are aiming to reduce the cost of manufacturing pharmaceutical lab equipment and devices.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/598285

Outsourcing of pharmaceutical devices is also on the rise across the globe. The rising use of third-party suppliers of lab equipment and devices is expected to create new growth opportunities in the global market. Suppliers of pharmaceutical lab equipment are responding to the changing trends and the changing needs of hospitals, healthcare centers, and medical care centers. The increasing number of pharmaceutical companies and the rising number of patients undergoing various surgeries and treatments have led to the increase in the number of pharmaceutical laboratories.

Rising government funding and improvements in the research and development activities have led to a rise in new drug discovery activities. Consistently rising drug development activities have boosted the demand for pharmaceutical laboratories. This is anticipated to boost the demand for lab equipment and medical testing devices in the coming years.   

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz

Global Medical Composite Materials Market To Grow At 6.91% CAGR From 2016 To 2020 Owing To Emergence Of Lightweight Composites

The report defines medical composite materials and briefs readers about the changing trends, competitive landscape, and the key companies operating in the market. Medical composite materials are compact products designed by generating a combination of components offering enhanced performance as compared to individual components. Medical composite materials offer benefits such as a high strength-to-weight ratio, good impact resistance, malleability, excellent fatigue endurance, and corrosion resistance. 

The growing awareness among manufacturers about the many benefits of medical composite materials has propelled the global market. The report, titled ‘Global Medical Composite Materials Market 2016-2020,’ states that the global market is predicted to exhibit a 6.91% CAGR during the period between 2016 and 2020. The emergence of lightweight composites and heat-resistant composites has driven the global market for medical composite materials in the last few years. However, the market is predicted to be challenged by the product differentiation of medical composites. The growing use of nano-fibers in soft tissue implants is predicted to benefit the global medical composite materials market.

Medical composite materials comprise fiber composites, polymer-ceramic composites, and polymer composites. As fiber composite materials offer good external impact resistance, they are increasingly being used for manufacturing numerous components including implants and prosthetics. Medical composite materials find application in diagnostic imaging, orthopedics, dental care, microspheres, and needles and syringes. The rising application of medical composite materials in diverse sectors is expected to benefit the global market throughout the forecast period.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/775780

The number of people facing dental issues is expanding rapidly across the globe. This has created more demand for dental composite materials. The rising number of dental patients has made the dental care segment one of the fastest growing application segments of the medical composite materials market.

For a detailed competitive landscape, the global medical composite materials market is regionally divided into APAC, North America, EMEA, and Rest of the World. The global market is highly competitive in nature, with key companies operating across many regions. With new product launches, key manufacturers of medical composite materials are expected to maintain their dominance in the global market. 3M, DSM, Polygone, PolyOne, Quatro, TenCate, Toray, C-K Composites, Evonik, Henkel, Icotec, and Mitsubishi Rayon are some of the key organizations operating in the global medical composite materials market. 

The introduction of new product offerings by key companies is predicted to make the global market competitive for the new entrants. Technological changes and improvements in the research and development activities have helped organizations in manufacturing new medical composite materials. By introducing lightweight composites, new entrants are anticipated to give tough competition to the key players operating in the market. 

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz

Global Market For Human Drugs For Veterinary Use To Grow Significantly With Increasing Number Of Innovative Drugs In Pipeline

The 60-page research report, titled “Human Drugs for Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs,” presents a detailed analysis of the market, emphasizing on the prime growth prospects and opportunities in the near future. The key growth drivers, current trends, challenges, and key geographical segments of the market have also been included in the scope of the research report. 

Furthermore, the research study throws light on the potential opportunities for the key players engaged in the global market for human drugs for veterinary use. The research study analyzes and determines the crossover drugs market, emphasizing on the differences between animal and human healthcare. The research study further identifies and assesses the prime differences between the animal and human healthcare markets.

Blockbuster drugs in human healthcare generate comparatively more than the drugs used in animal health market. As a result, several manufacturers engaged in formulating veterinary drugs are estimated to look for innovative products that already hold a license for human use. However, prescription of human drugs for veterinary use has some legal, safety, and health drawbacks, which are estimated to curtail the growth of the overall market in the next few years.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/731144

The research study presents insights into the extra-label drug use and highlights the growing applications in the veterinary sector. In addition, regulations and guidelines to be followed by professionals in the global animal health industry have been discussed in the scope of the research study. Furthermore, the competing treatments, disease overviews, cost of therapy, manufacturer information, dosage forms, and other insightful marketing data have been mentioned in the study. Some of the key marketed products that are used widely for chemotherapy in cats and dogs are Hydroxyzine, Bethanechol, Acetaminophen, Methimazole, Amlodipine, Phenobarbital, Levothyroxine, Humulin N, Sildenafil, and Pentoxifylline.

The research report further analyzes the prominent players operating in the global market for human drugs for veterinary use and throws light on the competitive landscape of the market. The key strategies adopted by the key players in order to sustain in the market are included in the research study in order to provide a clear picture of the market. Some of the leading players listed in the research study are Merck/MSD Animal Health, Boehringer Ingelheim Vetmedica, Zoetis, Elanco (Eli Lilly), and Merial (Sanofi).

The company overview, financial status, business policies, product segmentation, and recent news and developments in the global market for human drugs for veterinary use have been listed in the research report. In addition, recommendations given by the industry experts have also been included to offer a clear understanding of the market and guide the key players in making effective business decisions in the next few years.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz

Global Stem Cell Therapy Market Research To Witness Rapid Growth As Focus On Human Embryonic Stem Cells Grows

The 248-page research study, titled “PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy,” offers a detailed analysis of the market, throwing light on the key opportunities and trends in the overall market. The key growth drivers, challenges, product segmentation, vendor analysis, and key geographical segments of the global market for stem cell therapy have been discussed in the scope of the research report. 

Furthermore, the research study has taken help of numerous tools to determine the key growth drivers for the market and has presented the historical data and forecast figures of the market. The expected growth rate of the overall market has also been given in the research study in order to guide the decision-makers in designing effective business policies throughout the forecast period. 

Stem cell therapy is gaining immense popularity across the globe, due to which the overall market is estimated to witness significant growth in the next few years. The emergence of advanced genomic procedures for stem cell analysis, the rising focus on human embryonic stem cells, and the rising funding for new stem cell lines are some of the key factors estimated to augment the growth of the market in the next few years. In addition, the emergence of new and innovative stem cell therapies and developing markets that are expected to unfold new horizons, owing to the low regulatory hurdles, is anticipated to create several opportunities for the key players in the coming few years.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/232165

On the flip side, the absence of necessary infrastructure and the ethical issues concerning the use of embryonic stem cells are estimated to impede the growth of the stem cell therapy market across the globe in the coming few years. However, collaborations between leading pharmaceutical companies and the rising focus of key players on emerging markets are expected to generate potential opportunities throughout the forecast period.

The research study has classified the global market for stem cell therapy on the basis of cell type into fetal, amniotic, induced pluripotent, embryonic, cord blood-derived, and adult stem cells. The size of each segment and its expected growth rate in the coming years have been included in the research study in order to give a clear understanding of the market.

The research study throws light on the key players engaged in the stem cell therapy market across the globe and provides an in-depth analysis of the same. The prominent players operating in the market are Hygieia Innovation, Pharmicell, K-Stemcell, Neuralstem, Cellerant Therapeutics, Mesoblast, Stemedica, Tulane University, Bone Therapeutics, Celgene, Anterogen, NeoStem, StemCells, and Pluristem. The prime strategies adopted by the leading players in the market have also been highlighted in the study to guide the entrants in formulating their policies effectively in the next few years.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz

Global Biosimilars Market to grow at a CAGR of 55.52% during the period 2016-2020

MarketResearchReports.biz has recently announced the addition of a new market research report to its vast repository of research studies. The 152-page research report, titled “Global Biosimilars Market 2016-2020,” presents a detailed analysis of the market, emphasizing on the key growth factors and opportunities in the market. The past performance and predicted figures of the global biosimilars market have been presented in the research report, along with the growth rate to provide a clear understanding of the market. 

As per the research study, the global biosimilars market is projected to register a remarkable 55% CAGR between 2016 and 2020. The growing need for cost-effective treatments, increasing number of patent expiries, and reimbursement benefits for biosimilars are some of the prime factors estimated to bolster the growth of the global biosimilars market in the forecast period. In addition, the favorable government rules and regulations and promising pipeline are projected to augment the growth of the global biosimilars market in the near future. However, the risks associated with drug failures and limited availability of biosimilars are expected to curtail the growth of the market in the next few years.

On the basis of application, the global biosimilars market can be categorized into oncology, growth hormone deficiency diseases, blood disorders, and chronic and autoimmune diseases. In 2015, the blood disorders segment led the global biosimilars market with a 55% share. This segment is projected to witness rapid growth in the next few years, owing to the rise in the prevalence of blood disorders in emerging countries. Nevertheless, the introduction of alternative therapies is one of the key factors estimated to curtail the growth of the market in the coming few years.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/775744

The global biosimilars market has been classified on the basis of end use into hospitals and retail pharmacies. In 2015, the retail pharmacies segment accounted for a 52% share in the global biosimilars market and is estimated to remain in the leading position in the next few years. The rapid growth of this segment can be attributed to the growing consumer base for biosimilars across the globe.

The global biosimilars market is moderately competitive in nature thanks to the presence of several well-established players in the market. The leading players in the market are making efforts to expand their product horizon to sustain in the market. As per the study, the competitive scenario of the global biosimilars market is estimated to become intense, thanks to rising number of mergers and acquisitions taking place across the globe.

The prominent players in the global biosimilars market include Hospira, Dr. Reddy's Laboratories, STADA, Celltrion, Teva Pharmaceuticals, Sandoz, and Biocon. Some of the other players included in the research report are Intas Pharmaceuticals, Sanofi, Hetero Drugs, Amega Biotech, Aspen, Ranbaxy Laboratories, Merck, GSK, Momenta Pharmaceuticals, Allergan, Roche Holding, Boehringer Ingelheim, and Bio Sidus.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz